{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:39:55Z","timestamp":1765039195903,"version":"3.44.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K01AG027295"],"award-info":[{"award-number":["K01AG027295"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.clinthera.2013.02.024","type":"journal-article","created":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T20:49:09Z","timestamp":1364503749000},"page":"402-412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Medicare Part D Research Highlights and Policy Updates, 2013: Impact and Insights"],"prefix":"10.1016","volume":"35","author":[{"given":"JoAnn","family":"Stubbings","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denys T.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2013.02.024_bib2","unstructured":"Tudor CG. State of Part D: 2006\u20132012. Presented at:CMS2012 Medicare Prescription Drug Benefit Symposium, March 20\u201321, 2012, Hunt Valley, Md."},{"key":"10.1016\/j.clinthera.2013.02.024_bib4","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.clinthera.2012.02.012","article-title":"Medicare Part D research and policy highlights, 2012: Impact and insights","volume":"34","author":"Lau","year":"2012","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2013.02.024_bib5","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1377\/hlthaff.2012.0087","article-title":"The vast majority of Medicare Part D beneficiaries still don't choose the cheapest plans that meet their medication needs","volume":"31","author":"Zhou","year":"2012","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.clinthera.2013.02.024_bib6","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1681\/ASN.2011070740","article-title":"Sources of drug coverage among Medicare beneficiaries with ESRD","volume":"23","author":"Howell","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.clinthera.2013.02.024_bib7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.sapharm.2011.12.001","article-title":"Medicare part D information seeking: the role of recognition of need and patient activation","volume":"8","author":"Butler","year":"2012","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.clinthera.2013.02.024_bib8","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/1077558711435365","article-title":"One fish, two fish, red fish, blue fish: effects of price frames, brand names, and choice set size on Medicare Part D insurance plan decisions","volume":"69","author":"Barnes","year":"2012","journal-title":"Med Care Res Rev"},{"key":"10.1016\/j.clinthera.2013.02.024_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/qje\/qjr055","article-title":"Comparison friction: experimental evidence from Medicare drug plans","volume":"127","author":"Kling","year":"2012","journal-title":"Q J Econ"},{"key":"10.1016\/j.clinthera.2013.02.024_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/JCP.0b013e31823fb5c4","article-title":"Medicare Part D's impact on antipsychotic drug use and costs among elderly patients without prior drug insurance","volume":"32","author":"Polinski","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.clinthera.2013.02.024_bib11","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/acr.21696","article-title":"Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008","volume":"64","author":"Cheng","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.clinthera.2013.02.024_bib12","first-page":"e315","article-title":"Medicare Part D and potentially inappropriate medication use in the elderly","volume":"18","author":"Donohue","year":"2012","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.clinthera.2013.02.024_bib13","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1532-5415.2012.04031.x","article-title":"Effect of Medicare Part D benzodiazepine exclusion on psychotropic use in benzodiazepine users","volume":"60","author":"Ong","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.clinthera.2013.02.024_bib14","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1176\/appi.ps.201100331","article-title":"Medicare Part D benzodiazepine exclusion and use of psychotropic medication by patients with new anxiety disorders","volume":"63","author":"Ong","year":"2012","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.clinthera.2013.02.024_bib15","doi-asserted-by":"crossref","first-page":"776","DOI":"10.7326\/0003-4819-156-11-201206050-00004","article-title":"Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia","volume":"156","author":"Li","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2013.02.024_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/CIRCOUTCOMES.111.964866","article-title":"Beneficiaries with cardiovascular disease and the Part D coverage gap","volume":"5","author":"Polinski","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.clinthera.2013.02.024_bib17","first-page":"105","article-title":"The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure","volume":"15","author":"Baik","year":"2012","journal-title":"J Ment Health Policy Econ"},{"key":"10.1016\/j.clinthera.2013.02.024_bib18","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/archgenpsychiatry.2011.1402","article-title":"Effects of Medicare Part D coverage gap on medication and medical treatment among elderly beneficiaries with depression","volume":"69","author":"Zhang","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2013.02.024_bib19","first-page":"67","article-title":"Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gap","volume":"4","author":"Page","year":"2012","journal-title":"Drug Healthc Patient Saf"},{"key":"10.1016\/j.clinthera.2013.02.024_bib20","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/MLR.0b013e318269eb20","article-title":"Improvements in Medicare Part D risk adjustment: beneficiary access and payment accuracy","volume":"50","author":"Kautter","year":"2012","journal-title":"Med Care"},{"key":"10.1016\/j.clinthera.2013.02.024_bib21","first-page":"106","article-title":"Comparison of statin adherence among beneficiaries in MA-PD plans versus PDPs","volume":"18","author":"Jung","year":"2012","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.clinthera.2013.02.024_bib22","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/MLR.0b013e31826c85f9","article-title":"Impact of Part D low-income subsidies on medication patterns for Medicare beneficiaries with diabetes","volume":"50","author":"Stuart","year":"2012","journal-title":"Med Care"},{"key":"10.1016\/j.clinthera.2013.02.024_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/pop.2011.0008","article-title":"Quality of care, health care costs, and utilization among Medicare Part D enrollees with and without low-income subsidy","volume":"15","author":"Priest","year":"2012","journal-title":"Popul Health Manag"},{"key":"10.1016\/j.clinthera.2013.02.024_bib24","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1377\/hlthaff.2012.0019","article-title":"In Medicare Part D plans, low or zero copays and other features to encourage the use of generic statins work, could save billions","volume":"31","author":"Hoadley","year":"2012","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.clinthera.2013.02.024_bib25","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/j.1532-5415.2012.04073.x","article-title":"Association between the Part D coverage gap and adverse health outcomes","volume":"60","author":"Polinski","year":"2012","journal-title":"J Am Geriatr Soc"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2013.02.024_bib26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/pds.3250","article-title":"Confronting \u201cconfounding by health system use\u201d in Medicare Part D: comparative effectiveness of propensity score approaches to confounding adjustment","volume":"21","author":"Polinski","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.clinthera.2013.02.024_bib27","article-title":"Cost-related nonadherence by medication type among Medicare Part D Beneficiaries With Diabetes","author":"Williams","year":"2012","journal-title":"Med Care"},{"key":"10.1016\/j.clinthera.2013.02.024_bib28","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1053\/j.ajkd.2011.10.047","article-title":"Utilization and costs of cardiovascular disease medications in dialysis patients in Medicare Part D","volume":"59","author":"Frankenfield","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2013.02.024_bib29","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/j.1532-5415.2012.04037.x","article-title":"Ethnic disparities in adherence to antihypertensive medications of Medicare Part D beneficiaries","volume":"60","author":"Holmes","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.clinthera.2013.02.024_bib30","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.hrthm.2012.04.031","article-title":"Pharmacotherapy in Medicare beneficiaries with atrial fibrillation","volume":"9","author":"Piccini","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.clinthera.2013.02.024_bib31","first-page":"1","article-title":"Geographic variation in outpatient antibiotic prescribing among older adults","author":"Zhang","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2013.02.024_bib32","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1056\/NEJMsa1104816","article-title":"Sources of regional variation in Medicare Part D drug spending","volume":"366","author":"Donohue","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2013.02.024_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/CIRCOUTCOMES.111.962704","article-title":"Clopidogrel use and early outcomes among older patients receiving a drug-eluting coronary artery stent","volume":"5","author":"Roth","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.clinthera.2013.02.024_bib34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.amjmed.2011.08.014","article-title":"Concurrent use of warfarin and antibiotics and the risk of bleeding in older adults","volume":"125","author":"Baillargeon","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2013.02.024_bib35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/pds.3361","article-title":"Generic alendronate use among Medicare beneficiaries: are part d data complete?","volume":"22","author":"Yun","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.clinthera.2013.02.024_bib36","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/1077558712457595","article-title":"Validity of reported Medicare Part D enrollment in the medical expenditure panel survey","volume":"69","author":"Hill","year":"2012","journal-title":"Med Care Res Rev"},{"key":"10.1016\/j.clinthera.2013.02.024_bib37","doi-asserted-by":"crossref","first-page":"214","DOI":"10.5034\/inquiryjrnl_49.03.04","article-title":"Eligibility and take-up of the Medicare Part D low-income subsidy","volume":"49","author":"Shoemaker","year":"2012","journal-title":"Inquiry"},{"key":"10.1016\/j.clinthera.2013.02.024_bib38","first-page":"22072","article-title":"Medicare program; changes to the Medicare Advantage and the Medicare prescription drug benefit programs for contract year 2013 and other changes. Final rule with comment period","volume":"77","year":"2012","journal-title":"Fed Regist"},{"journal-title":"Memo to Part D Sponsors","article-title":"Transition to Part D coverage of benzodiazepines and barbiturates beginning in 2013","year":"2012","key":"10.1016\/j.clinthera.2013.02.024_bib39"},{"key":"10.1016\/j.clinthera.2013.02.024_bib40","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s11606-012-1993-9","article-title":"Access to and use of $4 generic programs in Medicare","volume":"27","author":"Zhang","year":"2012","journal-title":"J Gen Intern Med"},{"journal-title":"Memo to All Part D sponsors and capitated financial alignment demonstration contracts","article-title":"CY 2013 medication therapy management program guidance and submission instructions","year":"2012","key":"10.1016\/j.clinthera.2013.02.024_bib41"},{"key":"10.1016\/j.clinthera.2013.02.024_bib42","article-title":"Retrospective analysis of estimated cost avoidance following pharmacist-provided medication therapy management services","author":"Branham","year":"2012","journal-title":"J Pharma Pract"},{"key":"10.1016\/j.clinthera.2013.02.024_bib43","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1331\/JAPhA.2012.11258","article-title":"Outcomes of a Medicare Part D telephone medication therapy management program","volume":"52","author":"Moczygemba","year":"2012","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.clinthera.2013.02.024_bib45","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4140\/TCP.n.2012.269","article-title":"Impact of final short-fill rule on Medicare Part D costs and long term care pharmacy dispensing","volume":"27","author":"Bazalo","year":"2012","journal-title":"Consult Pharm"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291813001070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291813001070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:49:07Z","timestamp":1758962947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291813001070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0149291813001070"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2013.02.024","relation":{},"ISSN":["0149-2918"],"issn-type":[{"type":"print","value":"0149-2918"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medicare Part D Research Highlights and Policy Updates, 2013: Impact and Insights","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2013.02.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier HS Journals, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}